Stay updated on HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial

Sign up to get notified when there's something new on the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:44:36.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the information related to a Phase I clinical study evaluating the safety, pharmacokinetics, pharmacodynamics, and efficacy of HMPL-306 in patients with Relapsed/Refractory Myeloid Leukemia/Neoplasms and IDH1 and/or IDH2 Mutation.
    Difference
    0.2%
    Check dated 2024-06-06T14:29:54.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age, health conditions, and prior treatments required for the study. Previously, this section had no information provided.
    Difference
    17%
    Check dated 2024-05-22T21:12:31.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:21:27.000Z thumbnail image

Stay in the know with updates to HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page.